RETATRUTIDE — Triple Receptor Agonist Research Peptide

Retatrutide (RETA) is a next-generation triple receptor agonist research peptide studied for its interaction with GLP-1, GIP, and glucagon receptors. This advanced peptide has become a major focus in metabolic and obesity-related research due to its multi-pathway mechanism.

Researchers investigate Retatrutide for studies involving energy expenditure, appetite signaling, glucose metabolism, insulin sensitivity, and body composition pathways.

Mechanism of Action

Retatrutide is designed to simultaneously engage:

• GLP-1 receptors
• GIP receptors
• Glucagon receptors

This triple agonist mechanism is studied for synergistic metabolic pathway activation compared to traditional single-pathway compounds.

Research Applications

• Metabolic pathway studies
• Appetite signaling research
• Insulin sensitivity investigations
• Energy expenditure analysis
• Weight management pathway research
• Lipid metabolism studies

Product Specifications

• Purity: ≥99%
• Form: Lyophilized powder
• Storage: Refrigerate after reconstitution
• Research Grade Quality
• Laboratory Tested

For laboratory research only. Not for human or animal consumption.